3/17
10:09 am
zntl
Zentalis Pharmaceuticals (ZNTL) is now covered by Wells Fargo & Company. They set an "equal weight" rating and a $5.00 price target on the stock.
Low
Report
Zentalis Pharmaceuticals (ZNTL) is now covered by Wells Fargo & Company. They set an "equal weight" rating and a $5.00 price target on the stock.